ASHLYN CAREY: Open Payments
NPI 1174256093 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 71 payments from 15 companies in 2025. Trend: 2023 $1,391 · 2024 $1,521 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $383 |
| Janssen Biotech, Inc. | 6 | $194 |
| Ardelyx, Inc. | 11 | $148 |
| Regeneron Healthcare Solutions, Inc. | 6 | $130 |
| Madrigal Pharmaceuticals | 5 | $100 |
| GENZYME CORPORATION | 4 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Ipsen Biopharmaceuticals, Inc | 3 | $69 |
| Lilly USA, LLC | 4 | $66 |
| Intercept Pharmaceuticals, Inc. | 3 | $49 |
Products named: DUPIXENT, RINVOQ, TREMFYA, IBSRELA, SKYRIZI, REZDIFFRA, XIFAXAN, IQIRVO.
Industry payments across GA — which companies pay providers there.
